1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. PRIMARY CELL CULTURE MARKET BY CELL TYPE
5.1. Introduction
5.2. Epithelial Cell
5.3. Fibroblasts
5.4. Keratinocytes
5.5. Muscle Cells
5.6. Others
6. PRIMARY CELL CULTURE MARKET BY TYPE
6.1. Introduction
6.2. Human
6.3. Animal
7. PRIMARY CELL CULTURE MARKET BY METHOD
7.1. Introduction
7.2. Mechanical Disaggregation
7.3. Enzymatic Disaggregation
7.4. Primary Explant Technique
8. PRIMARY CELL CULTURE MARKET BY APPLICATION
8.1. Introduction
8.2. Cancer Research
8.3. Genetic Engineering
8.4. Vaccine Production
8.5. Virology
8.6. Drug Screening & Toxicity Testing
8.7. Others
9. PRIMARY CELL CULTURE MARKET BY END-USER
9.1. Introduction
9.2. Pharmaceuticals & Bio-Tech Companies
9.3. Research & Academic Institute
9.4. Others
10. PRIMARY CELL CULTURE MARKET BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. USA
10.2.2. Canada
10.2.3. Mexico
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Others
10.4. Europe
10.4.1. Germany
10.4.2. France
10.4.3. United Kingdom
10.4.4. Spain
10.4.5. Others
10.5. Middle East and Africa
10.5.1. Saudi Arabia
10.5.2. UAE
10.5.3. Israel
10.5.4. Others
10.6. Asia Pacific
10.6.1. China
10.6.2. India
10.6.3. Japan
10.6.4. South Korea
10.6.5. Indonesia
10.6.6. Thailand
10.6.7. Others
11. COMPETITIVE ENVIRONMENT AND ANALYSIS
11.1. Major Players and Strategy Analysis
11.2. Market Share Analysis
11.3. Mergers, Acquisitions, Agreements, and Collaborations
11.4. Competitive Dashboard
12. COMPANY PROFILES
12.1. Thermo Fisher Scientific, Inc.
12.2. Lonza
12.3. Merck KgaA
12.4. Corning Incorporated
12.5. Danaher Corporation
12.6. PromoCell GmbH
12.7. ATCC
12.8. FUJIFILM Corporation
12.9. Mattek (Sartorius)
12.10. Axol Bioscience Ltd
12.11. STEMCELL Technologies Inc.
13. APPENDIX
13.1. Currency
13.2. Assumptions
13.3. Base and Forecast Years Timeline
13.4. Key benefits for the stakeholders
13.5. Research Methodology
13.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES